Abstract
Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.
| Original language | English |
|---|---|
| Pages (from-to) | 278-287 |
| Number of pages | 10 |
| Journal | Current Infectious Disease Reports |
| Volume | 15 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 2013 |
Fingerprint
Keywords
- Antimycotic drugs
- Children
- Fungal infections
ASJC Scopus subject areas
- Infectious Diseases
Cite this
Antifungal agents in current pediatric practice. / Valerio, Cecinati; Perillo, Teresa; Brescia, Letizia; Russo, Fabio Giovanni.
In: Current Infectious Disease Reports, Vol. 15, No. 3, 06.2013, p. 278-287.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Antifungal agents in current pediatric practice
AU - Valerio, Cecinati
AU - Perillo, Teresa
AU - Brescia, Letizia
AU - Russo, Fabio Giovanni
PY - 2013/6
Y1 - 2013/6
N2 - Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.
AB - Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.
KW - Antimycotic drugs
KW - Children
KW - Fungal infections
UR - http://www.scopus.com/inward/record.url?scp=84878740646&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878740646&partnerID=8YFLogxK
U2 - 10.1007/s11908-013-0337-1
DO - 10.1007/s11908-013-0337-1
M3 - Article
C2 - 23616182
AN - SCOPUS:84878740646
VL - 15
SP - 278
EP - 287
JO - Current Infectious Disease Reports
JF - Current Infectious Disease Reports
SN - 1523-3847
IS - 3
ER -